Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

As global equity markets expand, two corporate heavyweights are emerging as serious contenders to reach $1 trillion in market capitalization by 2030.

Investors often view Pharmaceutical stocks ... Lilly, and Johnson & Johnson could face more immediate problems from international reference pricing. Each company has products that rank among the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...

The success of Eli Lilly & Co. 's weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the ...

We recently published a list of the Best Income Stocks to Invest in Now ... alongside Novo Nordisk. Eli Lilly and Company (NYSE:LLY)’s emphasis on high-demand, high-margin treatments is proving ...

That said, Eli Lilly could still hit the $1 trillion mark ... Visa has significant growth prospects. Lastly, it is a top income stock, too. Visa has increased its dividends by almost 392% in the past ...